458 related articles for article (PubMed ID: 20637078)
1. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
2. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.
Aryee DN; Niedan S; Kauer M; Schwentner R; Bennani-Baiti IM; Ban J; Muehlbacher K; Kreppel M; Walker RL; Meltzer P; Poremba C; Kofler R; Kovar H
Cancer Res; 2010 May; 70(10):4015-23. PubMed ID: 20442286
[TBL] [Abstract][Full Text] [Related]
4. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
6. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene.
Martens LK; Kirschner KM; Warnecke C; Scholz H
J Biol Chem; 2007 May; 282(19):14379-88. PubMed ID: 17374610
[TBL] [Abstract][Full Text] [Related]
8. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.
Zhang T; Kastrenopoulou A; Larrouture Q; Athanasou NA; Knowles HJ
BMC Cancer; 2018 May; 18(1):536. PubMed ID: 29739381
[TBL] [Abstract][Full Text] [Related]
10. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
Adamski J; Price A; Dive C; Makin G
PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
14. Kinome-wide functional genomics screen reveals a novel mechanism of TNFα-induced nuclear accumulation of the HIF-1α transcription factor in cancer cells.
Schoolmeesters A; Brown DD; Fedorov Y
PLoS One; 2012; 7(2):e31270. PubMed ID: 22355351
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
Nakazawa MS; Eisinger-Mathason TS; Sadri N; Ochocki JD; Gade TP; Amin RK; Simon MC
Nat Commun; 2016 Feb; 7():10539. PubMed ID: 26837714
[TBL] [Abstract][Full Text] [Related]
16. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.
Jeong CW; Yoon CY; Jeong SJ; Hong SK; Byun SS; Kwak C; Lee SE
Urol Oncol; 2013 Nov; 31(8):1448-56. PubMed ID: 22537539
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.
Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC
Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849
[TBL] [Abstract][Full Text] [Related]
18. Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.
Greve B; Sheikh-Mounessi F; Kemper B; Ernst I; Götte M; Eich HT
Strahlenther Onkol; 2012 Nov; 188(11):1038-47. PubMed ID: 23053158
[TBL] [Abstract][Full Text] [Related]
19. A novel series of G-quadruplex ligands with selectivity for HIF-expressing osteosarcoma and renal cancer cell lines.
Lombardo CM; Welsh SJ; Strauss SJ; Dale AG; Todd AK; Nanjunda R; Wilson WD; Neidle S
Bioorg Med Chem Lett; 2012 Sep; 22(18):5984-8. PubMed ID: 22889802
[TBL] [Abstract][Full Text] [Related]
20. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]